Moreover, oncogenic GTPase KRas (KRAS) induces NIX-mediated mitophagy and favors the development of pancreatic cancer, but the lack of NIX results in mitochondrial function restoration and thus delays the progression of pancreatic cancer [153]. The gene discussed is KRAS; the disease is pancreatic neoplasm.